Stock YP1A IMMUTEP ADR
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Immutep ADR Deutsche Boerse AG

Equities

YP1A

US45257L1089

Delayed Deutsche Boerse AG
Other stock markets
 02:16:58 2024-06-03 EDT 		5-day change 1st Jan Change
2.66 EUR +3.91% Intraday chart for Immutep ADR +3.10% +25.47%
10:57am Immutep, Merck Collaborate on Trial for Lung Cancer Therapy MT
07:20am Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial MT

Chart calendar Immutep ADR

456d6ad69a1ccd13.zwUk3tFlttnQA--NytkzAzC8A9TmO9Up5HAsXE5T0JQ.-jFxjI5Xx7DpTLfm_6pgRG-MbK6tYoBBhhdiOQ8jv6biSnO9izXzlJVUgA~838ff95fd81aacee44a1dec7aaedca36

Upcoming events on Immutep ADR

2024-08-27 Q4 2024 Earnings Release (Projected)
2025-02-19 Q2 2025 Earnings Release (Projected)
2025-08-26 Q4 2025 Earnings Release (Projected)
2026-02-18 Q2 2026 Earnings Release (Projected)

Past events on Immutep ADR

2024-05-30 American Society of Clinical Oncology Meeting
2024-05-14 European Society for Medical Oncology Meeting
2024-04-28 18:18 March 2024 Sales and Revenue Release - Activities Report
2024-02-27 17:39 Q2 2024 Earnings Release
2024-02-15 20:30 ShareCafe Hidden Gems Webinar
2024-02-05 23:40 Euroz Hartleys Healthcare Forum
2024-01-29 16:32 December 2023 Sales and Revenue Release - Activities Report
2024-01-07 JPMorgan Healthcare Conference
2023-11-15 10:00 Jefferies London Healthcare Conference
2023-11-13 Immuno-Oncology Europe Conference
2023-11-09 10:30 Baird Biotech Discovery Series
2023-11-03 12:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 595
2023-11-03 12:00 Society for Immunotherapy of Cancer Meeting - Abstract Number : 595
2023-10-31 AusBiotech Conference
2023-10-31 08:00 September 2023 Sales and Revenue Release - Activities Report
2023-10-24 Wilsons Drug and Device Healthcare Conference
2023-10-23 19:30 Annual General Meeting
2023-10-22 European Society for Medical Oncology Congress - Poster No: 1987TiP
2023-10-22 European Society for Medical Oncology Congress - Poster No: 1042P
2023-10-22 17:00 European Society for Medical Oncology Congress

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million AUD		Released
Forecast
Spread 		7,49
0,00
- 		16,5
13,0
26.47%		0,00
4,95
- 		6,76
4,04
67.13%		5,20
6,15
-15.41%
3,55

EBITDA
Million AUD		Released
Forecast
Spread 		-18,3
-7,55
-142.58%		0,00
0,00
- 		-17,6
-19,1
7.93%		-30,1
-35,5
15.3%		-37,8
-41,3
8.49%
-45,8

EBIT
Million AUD		Released
Forecast
Spread 		-20,2
-15,0
-34.9%		-12,3
-15,6
20.94%		-19,7
-24,1
18.34%		-32,1
-36,9
12.9%		-39,9
-44,2
9.86%
-47,1

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-18,3
-18,5
0.96%		-13,5
-15,4
12.69%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,4

Net income
Million AUD		Released
Forecast
Spread 		-18,3
-12,8
-43.47%		-13,5
-15,4
12.47%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,0

EPS
AUD		Released
Forecast
Spread 		-0,06
-0,03
-90%		-0,03
0,00
-1020%		-0,05
-0,04
-13.93%		-0,04
-0,04
12.63%		-0,04
-0,04
-3%
-0,04

Announcement Date20/08/1925/08/2030/08/2131/08/2229/08/23-

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million AUD		Released
Forecast
Spread





0,00
0,00
- 		0,00
1,08
- 		2,08
1,40
48.57%		3,91
3,20
22.07%


2,62
3,23
-19.05%		4,11
2,10
95.73%
1,20

EBITDA
Million AUD		Released
Forecast
Spread





-9,34
-9,40
0.62%		-8,24
-9,70
15%		-15,0
-15,1
0.99%		-15,7
-16,2
3.21%
-19,7


-21,8


-23,8


-23,6

EBIT
Million AUD		Released
Forecast
Spread 		-5,37
-5,10
-5.37%		-6,94
-9,52
27.09%		-10,4
-12,3
15.38%		-9,26
-13,5
31.62%		-16,8
-15,1
-11.65%		-15,9
-17,9
11.42%		-20,6
-19,0
-8.69%		-19,3
-22,6
14.77%		-21,2
-23,9
11.13%
-25,3

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.69%		-7,52
-9,57
21.42%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,0
11.44%		-20,6
-19,2
-7.18%		-19,3
-21,2
9.06%		-21,2
-23,7
10.48%
-24,3

Net income
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.7%		-7,52
-9,52
21%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,1
11.69%		-20,6
-12,8
-60.78%		-19,3
-21,9
11.98%		-21,2
-23,7
10.48%
-24,4

EPS
AUD		Released
Forecast
Spread





-0,04
-0,04
4.25%		-0,01
-0,03
52%		-0,02
-0,02
0%		-0,02
-0,02
15.91%		-0,02
-0,02
-2.61%


-0,02
-0,02
14.76%
-0,02

Announcement Date20/02/2025/08/2023/02/2130/08/2124/02/2331/08/2224/02/2329/08/2327/02/24-

Upcoming sector events for Immutep ADR

2024-07-15 01:45 ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Immutep ADR

2024-05-29 16:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 17:14 ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05 KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMM Stock
  4. YP1A Stock
  5. Calendar Immutep ADR